New York, May 21, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Outlook for Viral Vector Contract Manufacturing - Gene Therapies, Cell Therapies, and COVID-19 ...

Pall has secured a manufacturing contract with Exothera for the suspension-based manufacture of gene therapies and viral vector-based vaccines ... with the addition of two new state-of-the-art good ...

Scale Up and cGMP Manufacturing Services Forge will provide an adeno-associated viral (AAV) vector process, scale-up engineering and cGMP manufacturing services for SGT-003. The program will ...

Novasep's viral vector manufacturing business provides contract manufacturing services ... more than 7,000 square meters of state-of-the-art clinical and commercial manufacturing capacity.

COLLEGE STATION, Texas--(BUSINESS WIRE)--Matica Biotechnology, a leading Texas-based viral vector Contract ... vector manufacturing. The industry-leading experts at our state-of-the-art facility ...

Dublin, Nov. 12, 2020 (GLOBE NEWSWIRE) -- The "Global Contract Cell and Gene Therapy Manufacturing Market 2020-2026 - Supply Chain Optimization and Decentralized Manufacturing to Expand the ...

On Tuesday, VintaBio revealed $64 million in financing and a new Philadelphia manufacturing facility. The young contract development ... have emerged to fill viral vector manufacturing needs.

"As a leader in viral vector manufacturing, this increase in capacity and scale is the next step in enabling our customers to bring new curative treatments to market." This is the company's second ...

Additionally, the collaboration aims to advance both up-stream and down-stream processing of AAV and lentiviral vector manufacturing, including formulation development for long-term stability.

RELATED: $50M cell and viral vector manufacturing operation backed by Harvard Fujifilm is far from the only contract manufacturer answering the demand for viral vectors, either. Novartis and ...